Nicotine dependence
The DOI matches its Crossref record, with a small difference in title or year; 78 of the 79 references it cites were found in a registry or an index.
Abstract
Simple, rapid preclinical models of nicotine physical dependence and abstinence syndrome are needed to identify underlying neurobiological mechanisms and screen potential therapies. One such model induces dependence by 7 days of continuous subcutaneous nicotine infusion in the rat. Abstinence is initiated through termination of infusion or injection of nicotinic antagonist drugs. The result is an abstinence syndrome involving a pattern of behaviors somewhat resembling opiate abstinence in the rat as well as weight gain and depressed locomotor activity. The model has met a number of validity criteria and its essential features have been replicated in several laboratories. Several research groups have modified or extended the model by measuring emotional/motivational changes associated with nicotine abstinence such as conditioned aversion, intracranial self-stimulation (ICSS) thresholds and the startle response. Dependence models have been used to identify neurobiological systems that contribute to nicotine dependence, particularly endogenous opiate systems and the mesolimbic dopamine pathway. It is hypothesized that these different systems contribute to different behavioral aspects of nicotine abstinence syndrome. Increasingly used as a preclinical screening tool, the model has proved sensitive to various abstinence-alleviating therapeutic approaches, including some with already demonstrated clinical effectiveness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nicotine withdrawal following chronic passive administration in animals results in a syndrome with both somatic and affective components, including disrupted operant performance, avoidance behavior, weight gain, anxiety-like behaviors, decreased reward sensitivity, and opioid-like withdrawal behaviors (Malin, 2001; Hughes, 2007b).”
From Unique, long-term effects of nicotine on adolescent brain. (2020) · cites this paper as Malin, 2001
Citations
Cites
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Smoking withdrawal symptoms in two weeks of abstinence
Shiffman, S. M., & Jarvik, M. E. (1976) · Psychopharmacology · doi:10.1007/bf00634151 · Cited by 540
Rodent model of nicotine abstinence syndrome
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334
Self-citationAbsorption and metabolism of nicotine from cigarettes.
Armitage, A. K., Dollery, C. T., George, C. F., Houseman, T. H., Lewis, P. J., & Turner, D. M. (1975) · BMJ · doi:10.1136/bmj.4.5992.313 · Cited by 293
Circadian blood nicotine concentrations during cigarette smoking
Benowitz, N. L., Kuyt, F., & Jacob, P. (1982) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1982.233 · Cited by 291
Selective dopamine antagonists reduce nicotine self-administration
Corrigall, W. A., & Coen, K. M. (1991) · Psychopharmacology · doi:10.1007/bf02244174 · Cited by 281
Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor.
Kolesnikov, Y. A., Pick, C. G., Ciszewska, G., & Pasternak, G. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5162 · Cited by 275
The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence
Balfour, D. J. K., Wright, A. E., Benwell, M. E. M., & Birrell, C. E. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00202-3 · Cited by 231
Effects of nicotine on body weight and food consumption in rats
Grunberg, N. E., Bowen, D. J., & Morse, D. E. (1984) · Psychopharmacology · doi:10.1007/bf00427430 · Cited by 229
Tobacco withdrawal symptoms: An experimental analysis
Hatsukami, D. K., Hughes, J. R., Pickens, R. W., & Svikis, D. (1984) · Psychopharmacology · doi:10.1007/bf00427451 · Cited by 217
Watkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214
Schilström, B., Nomikos, G. G., Nisell, M., Hertel, P., & Svensson, T. H. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00243-1 · Cited by 207
Hildebrand, B. E., Nomikos, G. G., Hertel, P., Schilström, B., & Svensson, T. H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01135-9 · Cited by 200
The actions of nicotine and cocaine in a mouse model of anxiety
Costall, B., Elizabeth Kelly, M., Naylor, R. J., & Onaivi, E. S. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90450-4 · Cited by 186
Pentel, P. R., Malin, D. H., Ennifar, S., Hieda, Y., Keyler, D. E., Lake, J. R., Milstein, J. R., Basham, L. E., Coy, R. T., Moon, J. W. D., et al. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00206-3 · Cited by 179
Self-citationThe nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat
Malin, D. H., Ronald Lake, J., Carter, V. A., Scott Cunningham, J., Hebert, K. M., Conrad, D. L., & Wilson, O. B. (1994) · Psychopharmacology · doi:10.1007/bf02244770 · Cited by 165
Self-citationNeuroendocrine reactivity to nicotine in smokers
Pomerleau, O. F., Fertig, J. B., Seyler, L. E., & Jaffe, J. (1983) · Psychopharmacology · doi:10.1007/bf00439275 · Cited by 159
Naloxone precipitates nicotine abstinence syndrome in the rat
Malin, D. H., Lake, J. R., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1993) · Psychopharmacology · doi:10.1007/bf02244930 · Cited by 157
Self-citationAre NMDA receptors involved in opiate-induced neural and behavioral plasticity?
Trujillo, K. A. (2000) · Psychopharmacology · doi:10.1007/s002130000416 · Cited by 156
Nicotine self-administration in animals as a dependence model
Corrigall, W. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011121 · Cited by 156
FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat
Malin, D. H., Lake, J. R., Fowler, D. E., Hammond, M. V., Brown, S. L., Leyva, J. E., Prasco, P. E., & Dougherty, T. M. (1990) · Peptides · doi:10.1016/0196-9781(90)90082-g · Cited by 150
Self-citationFMRF-NH2-like mammalian octapeptide: Possible role in opiate dependence and abstinence
Malin, D. H., Lake, J. R., Hammond, M. V., Fowler, D. E., Rogillio, R. B., Brown, S. L., Sims, J. L., Leecraft, B. M., & Yang, H. T. (1990) · Peptides · doi:10.1016/0196-9781(90)90018-z · Cited by 144
Self-citationAnimal models of drug withdrawal symptoms
Emmett‐Oglesby, M. W., Mathis, D. A., Moon, R. T. Y., & Lal, H. (1990) · Psychopharmacology · doi:10.1007/bf02244046 · Cited by 141
Benwell, M. E. M., & Balfour, D. J. K. (1979) · Psychopharmacology · doi:10.1007/bf00426913 · Cited by 134
Hildebrand, B. E., Nomikos, G. G., Bondjers, C., Nisell, M., & Svensson, T. H. (1997) · Psychopharmacology · doi:10.1007/s002130050200 · Cited by 122
Effects of nicotine on body weight and food consumption in female rats
Grunberg, N., Bowen, D., & Winders, S. (1986) · Psychopharmacology · doi:10.1007/bf00172879 · Cited by 118
Effects of nicotine withdrawal on central dopaminergic systems
Fung, Y. K., Schmid, M. J., Anderson, T. M., & Lau, Y. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02063-2 · Cited by 117
Hildebrand, B. E., Panagis, G., Svensson, T. H., & Nomikos, G. G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00055-x · Cited by 110
IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat
Lake, J. R., Hammond, M. V., Shaddox, R. C., Hunsicker, L. M., Yang, H.-Y. T., & Malin, D. H. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90425-s · Cited by 108
Self-citationAdams, M. L., Kalicki, J. M., Meyer, E. R., & Cicero, T. J. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90472-f · Cited by 103
Mecamylamine-precipitated nicotine-withdrawal aversion in rats
Suzuki, T., Ise, Y., Tsuda, M., Maeda, J., & Misawa, M. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00723-6 · Cited by 103
Sites of action of ondansetron to inhibit withdrawal from drugs of abuse
Costall, B., Jones, B., Kelly, M. E., Naylor, R. J., Onaivi, E. S., & Tyers, M. B. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90132-2 · Cited by 101
Naloxone Challenge in Smokers: Preliminary Evidence of an Opioid Component in Nicotine Dependence
Krishnan-Sarin, S., Rosen, M. I., & O'Malley, S. S. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.7.663 · Cited by 101
Nicotine abstinence in the mouse
Isola, R., Vogelsberg, V., Wemlinger, T. A., Neff, N. H., & Hadjiconstantinou, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02131-9 · Cited by 100
Carboni, E., Bortone, L., Giua, C., & Di Chiara, G. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00064-2 · Cited by 96
LeSage, M. G., Keyler, D. E., Shoeman, D. W., Raphael, D. E., Collins, G., & Pentel, P. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00775-4 · Cited by 94
Gilbert, D. G., Meliska, C. J., Williams, C. L., & Jensen, R. A. (1992) · Psychopharmacology · doi:10.1007/bf02801984 · Cited by 94
Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase
Kimes, A. S., Vaupel, D. B., & London, E. D. (1993) · Psychopharmacology · doi:10.1007/bf02244904 · Cited by 90
Helton, D. R., Modlin, D. L., Tizzano, J. P., & Rasmussen, K. (1993) · Psychopharmacology · doi:10.1007/bf02245698 · Cited by 88
Chronic nicotine and withdrawal effects on body weight and food and water consumption in female rats
Levin, E. D., Morgan, M. M., Galvez, C., & Ellison, G. D. (1987) · Physiology & Behavior · doi:10.1016/0031-9384(87)90370-2 · Cited by 84
Vaupel, D. B., Kimes, A. S., & London, E. D. (1995) · Psychopharmacology · doi:10.1007/bf02245935 · Cited by 71
Cappendijk, S. L. T., VRIES, R. D., & Dzoljic, M. R. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90569-7 · Cited by 63
Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats
Ise, Y., Narita, M., Nagase, H., & Suzuki, T. (2000) · Psychopharmacology · doi:10.1007/s002130000482 · Cited by 63
Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome
Malin, D. H., Lake, J. R., Lin, A., Saldaña, M., Balch, L., Irvin, M. L. L., Chandrasekara, H., Alvarado, C. L., Hieda, Y., Keyler, D. E., et al. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00436-6 · Cited by 62
Self-citationPhysical Dependence on Nicotine in Gum: A Placebo Substitution Trial
Hughes, J. R. (1986) · JAMA · doi:10.1001/jama.1986.03370230083036 · Cited by 61
Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible
Malin, D. H., Lake, J. R., Payne, M. C., Short, P. E., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00202-2 · Cited by 60
Self-citationDoes switching to an ultra-low nicotine cigarette induce nicotine withdrawal effects?
West, R., Russell, M. A., Jarvis, M. J., & Feyerabend, C. (1984) · Psychopharmacology · doi:10.1007/bf00432039 · Cited by 58
Panagis, G., Hildebrand, B. E., Svensson, T. H., & Nomikos, G. G. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200001)35:1<15::aid-syn3>3.0.co;2-c · Cited by 54
Malin, D. H., Lake, J. R., Upchurch, T. P., Shenoi, M., Rajan, N., & Schweinle, W. E. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00028-8 · Cited by 52
Self-citationEffects of withdrawal from long-term nicotine gum use
West, R. J., & Russell, M. A. H. (1985) · Psychological Medicine · doi:10.1017/s0033291700005134 · Cited by 47
Harris, C. M., Emmett‐Oglesby, M. W., Robinson, N., & Lal, H. (1986) · Psychopharmacology · doi:10.1007/bf00172876 · Cited by 46
Nicotine Abstinence Syndrome Precipitated by Central But Not Peripheral Hexamethonium
Malin, D. H., Lake, J. R., Schopen, C. K., Kirk, J. W., Sailer, E. E., Lawless, B. A., Upchurch, T. P., Shenoi, M., & Rajan, N. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)90006-x · Cited by 45
Self-citationCorrelation between brain nitric oxide synthase activity and opiate withdrawal
Leza, J. C., Lizasoaín, I., Cuéllar, B., Moro, M. Á., & Lorenzo, P. L. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168639 · Cited by 45
Nicotine withdrawal in the rat: role of α7 nicotinic receptors in the ventral tegmental area
Nomikos, G. G., Hildebrand, B. E., Panagis, G., & Svensson, T. H. (1999) · Neuroreport · doi:10.1097/00001756-199903170-00007 · Cited by 45
Schedule-controlled behavior in the morphine-dependent rat
Ford, R. D., & Balster, R. L. (1976) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(76)90199-4 · Cited by 44
Evidence for a behavioral deficit during withdrawal from chronic nicotine treatment
Corrigall, W. A., Herling, S., & Coen, K. M. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90387-0 · Cited by 44
Rosecrans, J. A., Hendry, J. S., & Hong, J. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90141-8 · Cited by 42
Thompson, G. H., & Hunter, D. A. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17382 · Cited by 42
Auricular microelectrostimulation: Naloxone-reversible attenuation of opiate abstinence syndrome
Malin, D. H., Murray, J. B., Crucian, G. P., Schweitzer, F. C., Cook, R. E., & Skolnick, M. H. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90223-5 · Cited by 41
Self-citationMalin, D. H., Lake, J. R., Shenoi, M., Upchurch, T. P., Johnson, S. C., Schweinle, W. E., & Cadle, C. D. (1998) · Psychopharmacology · doi:10.1007/s002130050778 · Cited by 37
Self-citationCarroll, M. E., Lac, S. T., Asencio, M., & Keenan, R. M. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90025-8 · Cited by 37
Suzuki, T., Ise, Y., Mori, T., & Misawa, M. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00745-5 · Cited by 33
Jensen, R. A., Gilbert, D. G., Meliska, C. J., Landrum, T. A., & Szary, A. (1990) · Behavioral and Neural Biology · doi:10.1016/0163-1047(90)90310-3 · Cited by 33
Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF
Malin, D. H., Lake, J. R., Short, P. E., Blossman, J. B., Lawless, B. A., Schopen, C. K., Sailer, E., Burgess, K., & Wilson, O. B. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02279-1 · Cited by 32
Self-citationMalin, D. H., Lake, J. R., Smith, D. A., Jones, J. A., Morel, J., Claunch, A. E., Stevens, P. A., Payza, K., Ho, K. K., Liu, J., et al. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01178-1 · Cited by 31
Self-citationMecamylamine-precipitated nicotine-withdrawal aversion in Lewis and Fischer 344 inbred rat strains
Suzuki, T., Ise, Y., Maeda, J., & Misawa, M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00086-2 · Cited by 31
Nitric oxide mediates mecamylamine- and naloxone-precipitated nicotine withdrawal
Adams, M. L., & Cicero, T. J. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00089-2 · Cited by 30
Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons.
Rasmussen, K., & Czachura, J. F. (1995) · PubMed · Cited by 29
Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome
Malin, D. H., Lake, J. R., Arcangeli, K. R., Deshotel, K. D., Hausam, D. D., Witherspoon, W. E., Carter, V. A., Yang, H.-Y. T., Pal, B., & Burgess, K. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90601-x · Cited by 27
Self-citationPlasma enkephalin-like peptide response to chronic nicotine infusion in guinea pig
Hexum, T. D., & Russett, L. R. (1987) · Brain Research · doi:10.1016/0006-8993(87)90809-2 · Cited by 27
Central dopamine involvement in experimental gastrointestinal injury
Glavin, G. B. (1992) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(92)90073-n · Cited by 26
Hildebrand, B. E., & Svensson, T. (2000) · Journal of neural transmission · doi:10.1007/s007020070038 · Cited by 24
Balfour, D. J. K. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb05403.x · Cited by 23
Nicotine withdrawal leads to increased firing rates of midbrain dopamine neurons
Rasmussen, K., & Czachura, J. F. (1995) · NeuroReport · doi:10.1097/00001756-199512290-00079 · Cited by 22
Physical dependence on nicotine in gum. A placebo substitution trial
Hughes, J. R. (1986) · JAMA · doi:10.1001/jama.255.23.3277 · Cited by 22
Suh, H., Hudson, P. M., McMillian, M., Das, K. P., Wilson, B. C., Wu, G.-Q., & Hong, J. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12231-3 · Cited by 17
Contribution of Glutamate Receptors to Benzodiazepine Withdrawal Signs
Tsuda, M., Shimizu, N., & Suzuki, T. (1999) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.81.1 · Cited by 16
Cerebrospinal fluid from morphine-dependent rats precipitates opiate abstinence syndrome
Malin, D. H., Harter, L., Jenkins, P. D., Monfort, R., Bruce, P. D., Farley, P. A., Ferebee, R. N., Thrasher, K. L., & Marullo, D. S. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90163-9 · Cited by 11
Self-citation
Research works printed but not linked: 3
- Center for Disease Control. Cigarette smoking-attributable mortality and years of potential life lost. Morb Mortal Wkly Rep 1993;42:504–9, 645–9.
- Damaj, 2000, Nicotine abstinence syndrome in the mouse, Soc Res Nicotine Tob Proc, 6, 32
- Persico, 1995, Acetyl-l-carnitine stereospecifically attenuates nicotine abstinence syndrome in the rat and facilitates smoking cessation in an open one-year follow-up trial, Soc Neurosci Abstr, 21, 722
Cited by
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Guidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824
Cue dependency of nicotine self-administration and smoking
Caggiula, A. R., Donny, E. C., White, A. R., Chaudhri, N., Booth, S., Gharib, M. A., Hoffman, A., Perkins, K. A., & Sved, A. F. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00676-1 · Cited by 428
Motivational Influences on Cigarette Smoking
Baker, T. B., Brandon, T. H., & Chassin, L. (2004) · Annual Review of Psychology · doi:10.1146/annurev.psych.55.090902.142054 · Cited by 352
“This may reflect the relatively higher doses given animals (Malin 2001) as well as species differences.”
BackgroundInfluentialAmiaz, R., Levy, D., Vainiger, D., Grunhaus, L., & Zangen, A. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02448.x · Cited by 313
Metadata
- Authors
- Malin, D. H.
- Affiliations
- University of Houston - Clear Lake (US)
- Corresponding author
- Malin, David H.
- ORCID
- Malin, David H.
- Venue
- Pharmacology Biochemistry and Behavior
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 70
- Issue
- 4
- Pages
- 551-559
- ISSN
- 0091-3057 (ISSN-L)
- OpenAlex
- W29281053
- Cited by
- 167
- References
- 79
- Citations by year
- 2023: 1 · 2022: 2 · 2021: 3 · 2020: 24 · 2019: 7 · 2017: 3 · 2016: 5 · 2015: 4 · 2014: 6 · 2013: 12 · 2012: 3
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Pharmacology Biochemistry and Behavior (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1u19da013327-01, 1r55da008260-01a2)
- National Institute on Drug Abuse (DA 08260, R01DA010714, DA13327, DA10714)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotine dependence, preclinical animal models, nicotinic antagonists, opioid withdrawal, conditioned aversion, intracranial self-stimulation, startle response, endogenous opioid system, mesolimbic dopamine system, locomotor activity, weight gain
- MeSH terms
- Animals, Disease Models, Animal, Humans, Tobacco Use Disorder, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.